BUHLMANN News

BUHLMANN fCAL ELISA Promotion

An FDA-Cleared Gastrointestinal Test to Distinguish IBD from IBS Calprotectin is a highly-sensitive clinical biomarker shown to be extremely useful ...
Read More
IBDoc-webinar-recording

IBDoc® Talk – Tips and Tricks Teleconference

Health Canada Licence: 98903, Device class: 3  BÜHLMANN IBDoc® is not available for sale in the US. IBDoc® is the first self-testing application ...
Read More

BUHLMANN Quantum Blue® fCAL Tutorial

View this demonstration of CALEX® Cap extraction and quantitative fecal calprotectin measurement using the Quantum Blue® fCAL rapid test technology. Quantum ...
Read More

Can mHealth Apps replace clinic visits?

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a ...
Read More

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a ...
Read More

IBDoc – SwissMedtech Award Nominee

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 BÜHLMANN was ...
Read More

First IBD Nurse Led IBDoc Study

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Pearl Avery, ...
Read More
Loading...